Maximizing Outcomes in Relapsed/Refractory Multiple Myeloma: Tailoring Bispecific Antibody Approaches : Episode 7
Elranatamab: Real-World Experience and Sequencing
In this segment, Dr Mohan asks Dr Nadeem about the real-world performance of elranatamab, its advantages and challenges in clinical practice, and the next therapeutic approach if a patient experiences disease progression on elranatamab.
Video content above is prompted by the following:
- Based on your clinical experience, how has elranatamab performed in real-world practice?
- What advantages and challenges have you encountered when incorporating elranatamab into your treatment protocols?
- If this patient were to experience disease progression on elranatamab, what would be your next therapeutic approach and why?
- What considerations would guide your decision-making process?
Recent Videos
Related Content
